Table 2.
Characteristics of patients with chronic plaque psoriasis.
| Characteristic | PsV (n = 70) | PsV type I (n = 49) | PsV type II (n = 21) | PsV with elevated CRP (n = 19) | PsV with increased ESR (n = 34) | PsV with borderline LDL (n = 16) | PsV with prediabetes (n = 21) | Controls (n = 59) |
|---|---|---|---|---|---|---|---|---|
| Age mean ± SD (years) | 49.33 ± 17.95 | 42.92 ± 16.13 | 63.55 ± 11.93 | 54.79 ± 18.96 | 54.43 ± 16.38 | 52.50 ± 13.21 | 57.95 ± 11.55 | 47.05 ± 13.93 |
| Male n (%)/ female n (%) |
35 (50%) 35 (50%) |
24 (48.97%) 25 (51.03%) |
11 (52.39%) 10 (47.61%) |
10 (52.63%) 9 (47.37%) |
16 (47.05%) 18 (52.95%) |
7 (43.75%) 9 (56.25%) |
10 (47.61%) 11 (52.39%) |
29 (49.1%) 30 (50.8%) |
| PASI mean ± SD | 10.85 ± 7.07 | 11.02 ± 6.43 | 10.44 ± 7.021 | 11.88 ± 5.98 | 10.92 ± 5.832 | 10.02 ± 4.457 | 10.46 ± 4.4 | |
| BSA mean ± SD (%) | 23.39 ± 15.94 | 23.80 ± 13.15 | 22.40 ± 16.44 | 25.25 ± 16.06 | 23.38 ± 14.33 | 17.98 ± 13.09 | 18.44 ± 10.52 | |
| BMI mean ± SD | 26.12 ± 3.39 | 25.88 ± 3.66 | 26.68 ± 2.656 | 27.89 ± 2.031 | 27.16 ± 3.06 | 26.77 ± 2.662 | 28.33 ± 1.57 | |
| CRP mean ± SD (mg/dl) | 5.96 ± 9.79 | 4.63 ± 5.25 | 9.086 ± 15.80 | 15.45 ± 15.52 | 9.04 ± 12.54 | 6.306 ± 8.143 | 5.473 ± 4.751 | |
| ESR mean ± SD (mm) | 16.83 ± 13.89 | 13.50 ± 9.39 | 24.35 ± 19.51 | 23.28 ± 18.57 | 26.13 ± 14.44 | 15.77 ± 9.339 | 22.76 ± 11.70 | |
| LDL mean ± SD (mg/dl) | 108.30 ± 28.85 | 106.0 ± 27.97 | 113.7 ± 30.82 | 114.9 ± 23.54 | 108.5 ± 29.24 | 147.4 ± 7.164 | 117.8 ± 26.65 | |
| HbA1c mean ± SD (%) | 5.38 ± 0.47 | 5.297 ± 0.446 | 5.579 ± 0.46 | 5.6 ± 0.59 | 5.49 ± 0.55 | 5.453 ± 0.151 | 5.94 ± 0.226 | |
| SAF mean ± SD | 1.89 ± 0.59 | 1.665 ± 0.391 | 2.431 ± 0.638 | 2.037 ± 0.446 | 2.059 ± 0.52 | 2.093 ± 0.59 | 2.213 ± 0.526 | 1.816 ± 0.38 |
PsV: patients with chronic plaque psoriasis.